SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ

article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

Bazedoxifene treatment significantly reduced lesion volumes and improved histopathological structures in a rat model of endometriosis, suggesting its potential as an alternative therapeutic option for the condition.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-27 · read from full text ⓘ

This study investigated the therapeutic potential of bazedoxifene, a selective estrogen receptor modulator, in a rat model of surgically induced endometriosis. The researchers administered the drug to evaluate its effects on lesion size and associated inflammatory markers compared to control groups. Results indicated that bazedoxifene treatment led to significant regression of endometriotic lesions, demonstrating its efficacy in reducing disease burden in this experimental setting. This paper is centrally about endometriosis — specifically evaluating a pharmacological intervention using a selective estrogen receptor modulator in an animal model of the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Aim: The only factor that is proved on the pathogenesis of endometriosis is estrogen. The aim of this study is to investigate the effect of bazedoxifene, a third generation selective estrogen receptor modulator, on the endometriotic implants in the rat endometriosis model by using histopathological examination and immunohistochemical assays. Materials and Method: This randomized, placebocontrolled, experimental study was conducted in the Animal Research Laboratory at Ankara Education and Research Hospital. The study was performed on 20 Wistar female albino rats. Experimental endometriosis model was constituted with implantation of autologous endometrial tissue on the right side of the pelvic wall. The endometriotic implants were examined by second laparatomy after 30 days, and the rats were divided randomly into two groups. Group 1 received 3 mg/ kg Bazedoxifene (n =10) per oral, once a day, for 30 more days. Group 2 (n =10) was the control group and did not receive any medical treatment. After 30 days of treatment period, the third laparatomy was performed, endometriotic lesions volumes were measured, and endometriotic foci were extracted for histopatological and immunohistochemical evaluation. Histopathological scoring was evaluated according to preservation of epithelial layer. In addition, endometrial implants were evaluated immunohistochemically for VEGF, MMP-2 and MMP-9. Results: The volumes of the lesions were smaller in the group which was treated with bazedoxifene than the ones in the control group which was statistically significant (p 0.05). Conclusion: Bazedoxifene treatment was seen to have a regressive effect on the volumes and histopathological structure of endometriotic implants. Bazedoxifene could be regarded as a new alternative in the treatment of endometriosis.
Full text 2,037 characters · extracted from oa-html · click to expand
SELEKTİF ESTROJEN RESEPTÖR MODÜLATÖRÜ OLAN BAZEDOKSİFENİN RAT MODELİNDE OLUŞTURULAN ENDOMETRİOZİS TEDAVİSİNDEKİ ROLÜ Öz Anahtar Kelimeler Kaynakça - Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 2002;955:159–73. 2. Wheeler JM, Malinak LR. Recurrent endometriosis: incidence, management, and prognosis. Am J Obstet Gynecol 1983; 146(3):247-53. - Taylor E, Williams C. Surgical treatment of endometriosis: location and patterns of disease at reoperation. Fertil Steril 2010; 93:57-61. - Kulak J Jr, Fischer C, Komm B, Taylor HS. Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology 152(8):3226-32. 2011doi: 10.1210/en.2010-1010. Epub 2011 May 17. - Komm BS, Kharode YP, Modine PV, Harris HA, Miller CP, Lyttle CR. Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology 2005;146:3999-4008. - Ronkin S, Northington R, Baracat E, et al. Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women. Obstet Gynecol 2005;105(6):1397-404. - Morello KC, Wurz GT, DeGregorio MW. Pharmacokinetics of selective estrogen receptor modulators. Clin Pharmacokinet 2003;42:361-72. - Chris P. Spencer, MD, Edward P. Morris and Janice M. Selective estrogen receptor modulators: Women’s panacea for the next millennium? Am J Obstet Gynecol 1999; 180: 763-70. - Maeda K, Ohkura S, Tsukamura H. Physiology of the reproduction. In: Krinke GJ, editor. The laboratory rat (Handbook of experimental animals) London:Academic Press; 2000.p.148-149 Ayrıntılar Birincil Dil Türkçe Konular - Bölüm - Yazarlar Senem Mine Keskin Bu kişi benim Hacer Cavidan Gülerman Bu kişi benim Özlem Uzunlar Bu kişi benim Şebnem Özyer Bu kişi benim Ayla Aktulay Bu kişi benim Muzaffer Çaydere Bu kişi benim Yayımlanma Tarihi 1 Temmuz 2013 Gönderilme Tarihi - Kabul Tarihi - Yayımlandığı Sayı Yıl 2013 Cilt: 10 Sayı: 39

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK